Diadema Partners LP Bridge Bio Pharma, Inc. Transaction History
Diadema Partners LP
- $383 Billion
- Q1 2025
A detailed history of Diadema Partners LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 131,400 shares of BBIO stock, worth $6.12 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
131,400Holding current value
$6.12 Million% of portfolio
1.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BBIO
# of Institutions
387Shares Held
184MCall Options Held
12.8MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$1.03 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$897 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$694 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$580 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$334 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.91B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...